| Also known as |
AC-262536 |
| Blood pressure |
No significant impact reported |
| Chemical name |
4-(3-hydroxy-6-methyl-2,5,7-trien-1-yl)-2-trifluoromethylbenzonitrile |
| Dosage (medical) |
Not medically approved or specified |
| Dosage (sports) |
Typically 5-10 mg per day |
| Effects |
Increased muscle mass, strength, and bone density |
| Formula |
C18H18F3NO |
| Half-life |
4-6 hours |
| Hepatotoxicity |
Low to none reported |
| Lab Test |
Detection via specific chromatographic and mass spectrometric methods |
| Main action |
Selective androgen receptor modulation |
| Model |
BS ACCADRINE (AC262) |
| Reward Points |
RECEIVE 10 REWARD POINTS |
| Side effects |
Potential for testosterone suppression, unknown long-term effects |
| Stock |
IN STOCK |
| Storage conditions |
Store at room temperature, protect from light and moisture |
| Substance class |
Selective Androgen Receptor Modulator (SARM) |
| Trade name |
Not commercially marketed under any specific trade name |
| Use in sports |
Performance enhancement (not approved or legal for sports use) |
| Water Retention |
Minimal |
| Manufacturer |
BIAXOL |
